Project Grant R61NS135584
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$1M
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This federal Project Grant award of $169,000.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development of a comprehensive online database and web application for neurometabolic diseases. The key products to be delivered include: (1) the creation of a database containing clinical, biochemical, radiological, and therapeutic data on over...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program provides $1,475,752.49 to New York University School of Medicine to conduct research on multiple system atrophy (MSA), a rare neurodegenerative disease. The research aims to generate single-cell transcriptomic profiles of brain tissue from MSA patients to identify key...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to utilize omics approaches and machine learning to develop novel prognostic and monitoring biomarkers for adrenomyeloneuropathy (AMN), the most common adult neurologic variant of X-linked adrenoleukodystrophy (X-ALD). The $1,664,933 award, with a performance period from August...
This $596,783 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program supports research to harness mitochondria transfer pathways as a potential therapeutic strategy for treating Leigh syndrome, a fatal inherited mitochondrial disease. The research aims to determine how administering exogenous mitochondria and bone marrow...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $155,000.00 to the Regents of the University of Minnesota to conduct research on assessing cervical spinal pathology in patients with mucopolysaccharidosis (MPS) types I, II, and VI. The research aims to: Assess longitudinal morphological changes in the cervical spinal cord of MPS...
This $443,354 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate metabolic dependencies and resistance mechanisms in pediatric diffuse midline glioma (DMG) brain tumors harboring the H3K27M mutation. The research aims to understand how targeting the hexosamine biosynthetic pathway, either alone or in...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $694,134.00 to The Trustees of the University of Pennsylvania to conduct research focused on using engineered hematopoietic stem cells (HSCs) to replace dysfunctional microglia in the treatment of Globoid Cell Leukodystrophy (GLD, also known as Krabbe disease). The...
This $410,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to understand the mechanisms behind amylopectinosis, a rare condition characterized by the formation of insoluble polyglucosan bodies, in the context of linear ubiquitin chain assembly complex (LUBAC) deficiency. The study, led by Principal Investigator Dr. Sharmistha Mitra...
This Project Grant award from the National Institute of Child Health and Human Development under CFDA 93.865 "Child Health and Human Development Extramural Research" provides $1,313,434.00 to the Children's Mercy Hospital in Kansas City, Missouri to conduct research on unraveling the genomic causes for unsolved leukodystrophy patients. The primary goals are to utilize long-read genome sequencing (HIFI-GS) to identify complex genetic variants, such as repeat expansions and structural...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,208,638 to Emory University to investigate the therapeutic potential of targeting NADH-reductive stress in mitochondrial diseases. The key objectives are to: (A) assess how an engineered enzyme called LOXCAT impacts metabolism and mitochondrial function in primary cell...